Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07542756 · ClinicalTrials.gov registry record · Phase 4
A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia
A Phase 4 study, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 1,200
- Enrollment target
NCT07542756: Recruiting Phase 4 study, sponsored by University of Pennsylvania.
NCT07542756 is a Phase 4 study that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07542756, a Phase 4 study, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the relative effectiveness, safety, and durability of the most commonly used prescription (zolpidem, trazodone) and over-the-counter (OTC) (melatonin, diphenhydramine) medications for insomnia, as well as a less commonly used prescription that may have a better risk/benefit profile (doxepin).
Interventions
- OTHER Sleep Hygiene Education
- DIETARY_SUPPLEMENT Melatonin IR, 3 mg
- DIETARY_SUPPLEMENT Melatonin IR, 5 mg
- DRUG Diphenhydramine, 25 mg
- DRUG Diphenhydramine, 50 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2032-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07542756
The ClinicalTrials.gov registry entry for NCT07542756 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Sleep Hygiene Education is the first listed.
NCT07542756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07542756 about?
NCT07542756 is a clinical study titled "A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia". The purpose of this study is to assess the relative effectiveness, safety, and durability of the most commonly used prescription (zolpidem, trazodone) and over-the-counter (OTC) (melatonin, diphenhydramine) medications for insomnia, as well as a less commonly used prescription that may have a better...
What is the current status of trial NCT07542756?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 1,200 participants. The study started on 2026-05-01. Estimated completion is 2032-01-01.
What interventions are being tested in trial NCT07542756?
The interventions under investigation include: Sleep Hygiene Education (OTHER), Melatonin IR, 3 mg (DIETARY_SUPPLEMENT), Melatonin IR, 5 mg (DIETARY_SUPPLEMENT), Diphenhydramine, 25 mg (DRUG), Diphenhydramine, 50 mg (DRUG).
Who is sponsoring clinical trial NCT07542756?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.